| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 915,953 | 857,341 | 635,396 | 889,965 | | Cost of Revenue | 522,123 | 499,225 | 400,738 | 533,239 | | | Gross Profit | 393,830 | 358,116 | 234,658 | 356,726 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 273,199 | 259,215 | 265,618 | 278,982 | | Non Recurring |
-
| 15,462 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 120,631 | 83,439 | (30,960) | 77,744 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,094 | (5,794) |
-
|
-
| | Earnings Before Interest And Taxes | 121,725 | 77,645 | (30,960) | 77,744 | | Interest Expense | 12,797 | 12,960 | 13,520 | 17,394 | | Income Before Tax | 108,928 | 64,685 | (44,480) | 60,350 | | Income Tax Expense | 35,903 | 25,379 | (13,547) | 18,624 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 73,025 | 39,306 | (30,933) | 41,726 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 73,025 | 39,306 | (30,933) | 41,726 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $73,025 | $39,306 | ($30,933) | $41,726 |
|
0.02% Nasdaq 0.00%
Income Statement
